"Uw vertrouwde ziekenhuis in Utrecht"

During the past decade, Diakonessenhuis - Locatie Utrecht conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diakonessenhuis - Locatie Utrecht" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Diakonessenhuis - Locatie Utrecht" are "Paroxysmal Supraventricular Tachycardia" (1 trials), "Recurrent Symptomatic Atrial Fibrillation" (1 trials) and "Syncope" (1 trials). Many other conditions were trialed in "Diakonessenhuis - Locatie Utrecht" in a lesser frequency.

Most popular intervention types in "Diakonessenhuis - Locatie Utrecht" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etripamil" (1 trials), "Insertable Cardiac Monitor Implant" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diakonessenhuis - Locatie Utrecht" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Diakonessenhuis - Locatie Utrecht". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Diakonessenhuis - Locatie Utrecht, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diakonessenhuis - Locatie Utrecht, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".